Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical businesses, which includes the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use – and failure to complete so may be grounds for compensation. Our lawyers are working tough to have these hurt by the drug the compensation they are entitled to.
Although bleeding is actually a widespread complication linked with anticoagulants, it has been alleged that Xarelto is much more dangerous than classic blood thinners because no antidote exists to reverse its blood-thinning side effects of xarelto rivaroxaban. This indicates that, inside the event of an emergency, sufferers could be at danger for irreversible bleeding difficulties, which includes life-threatening internal and gastrointestinal hemorrhaging.
Should you or a loved 1 suffered a severe bleeding occasion following taking Xarelto, you might have legal recourse. For more data, get in touch with us nowadays to have your case reviewed, cost-free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future medical bills, lost wages, discomfort and suffering and, in cases of death, funeral costs. Furthermore, they are seeking punitive damages, which are generally awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Getting Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs inside the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.
Visit this page for much more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.